糖尿病足诊断影像学:EANM循证指导
欧洲核医学协会(EANM)工作组通过系统文献分析,针对糖尿病足感染与非感染并发症的影像学诊断提出7条循证推荐。内容涵盖骨探针试验阳性、疑似骨髓炎、夏科足及叠加感染等场景下MRI、白细胞闪烁显像、[18F]FDG PET/CT的选择与联合应用。
要点
- 骨探针试验阳性、平片阳性且ESR升高的患者应按推定骨髓炎治疗。
- 需评估感染范围或严重程度时,可考虑MRI联合白细胞闪烁显像或[18F]FDG PET/CT。
- 疑似骨髓炎但平片阴性时,需先进影像(MRI、白细胞闪烁显像+SPECT/CT或[18F]FDG PET/CT)评估范围。
核心结论
- 本文件提供循证推荐,旨在明确不同临床场景下应优先选择何种影像学方法。
- 共形成9个临床问题并据此给出7条循证推荐。
研究设计与样本
- 工作组包括EANM任命的8名核医学医师、3名放射科医师和3名临床医师(糖尿病科、足病科和感染病科各1名)。
- 临床问题通过PICO策略进行系统文献分析并转化为陈述,每条共识按OCEBM标准评分证据等级和推荐等级。
主要发现
- 骨探针试验阳性、平片阳性且ESR升高的患者应按推定骨髓炎治疗。
- 需更好评估感染位置、范围或严重程度以制定更个体化治疗时,应考虑MRI联合白细胞闪烁显像或[18F]FDG PET/CT。
- 疑似骨髓炎、骨探针试验阳性但平片阴性时,需MRI或白细胞闪烁显像+SPECT/CT或[18F]FDG PET/CT准确评估感染范围。
- 无循证数据支持在前足、中足和后足骨髓炎或软组织感染检测中明确优先选择某一种影像方法;MRI通常为首选先进影像,结果不明确时使用放射性标记白细胞显像或[18F]FDG PET/CT。
- MRI是诊断或排除夏科神经骨关节病的首选方法,[18F]FDG PET/CT可作为替代;评估夏科足是否叠加感染时,白细胞闪烁显像在区分骨髓炎与夏科关节病方面可能比[18F]FDG PET/CT更准确。
关键数值与推荐
- 推荐1:骨探针试验阳性、平片阳性且ESR升高的患者应按推定骨髓炎治疗。
- 推荐2:需更好评估感染位置、范围或严重程度以制定更个体化治疗时,应考虑MRI联合白细胞闪烁显像或[18F]FDG PET/CT。
- 推荐3:疑似骨髓炎、骨探针试验阳性但平片阴性时,需MRI或白细胞闪烁显像+SPECT/CT或[18F]FDG PET/CT准确评估感染范围。
- 推荐4:无循证数据支持在前足、中足和后足骨髓炎或软组织感染检测中明确优先选择某一种影像方法;MRI通常为首选先进影像,结果不明确时使用放射性标记白细胞显像或[18F]FDG PET/CT。
- 推荐5:MRI是诊断或排除夏科神经骨关节病的首选方法,[18F]FDG PET/CT可作为替代;推荐6:评估夏科足是否叠加感染时,白细胞闪烁显像在区分骨髓炎与夏科关节病方面可能比[18F]FDG PET/CT更准确。
临床怎么用
- 临床怀疑感染持续存在但影像阴性时,可考虑追加其他影像学方法。
- 应尽可能进行微生物学或组织学评估以确认诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Consensus on the choice of the most accurate imaging strategy in diabetic foot infective and non-infective complications is still lacking. This document provides evidence-based recommendations, aiming at defining which imaging modality should be preferred in different clinical settings. METHODS: This working group includes 8 nuclear medicine physicians appointed by the European Association of Nuclear Medicine (EANM), 3 radiologists and 3 clinicians (one diabetologist, one podiatrist and one infectious diseases specialist) selected for their expertise in diabetic foot. The latter members formulated some clinical questions that are not completely covered by current guidelines. These questions were converted into statements and addressed through a systematic analysis of available literature by using the PICO (Population/Problem-Intervention/Indicator-Comparator-Outcome) strategy. Each consensus statement was scored for level of evidence and for recommendation grade, according to the Oxford Centre for Evidence-Based Medicine (OCEBM) criteria. RESULTS: Nine clinical questions were formulated by clinicians and used to provide 7 evidence-based recommendations: (1) A patient with a positive probe-to-bone test, positive plain X-rays and elevated ESR should be treated for presumptive osteomyelitis (OM). (2) Advanced imaging with MRI and WBC scintigraphy, or [18F]FDG PET/CT, should be considered when it is needed to better evaluate the location, extent or severity of the infection, in order to plan more tailored treatment. (3) In a patient with suspected OM, positive PTB test but negative plain X-rays, advanced imaging with MRI or WBC scintigraphy + SPECT/CT, or with [18F]FDG PET/CT, is needed to accurately assess the extent of the infection. (4) There are no evidence-based data to definitively prefer one imaging modality over the others for detecting OM or STI in fore- mid- and hind-foot. MRI is generally the first advanced imaging modality to be performed. In case of equivocal results, radiolabelled WBC imaging or [18F]FDG PET/CT should be used to detect OM or STI. (5) MRI is the method of choice for diagnosing or excluding Charcot neuro-osteoarthropathy; [18F]FDG PET/CT can be used as an alternative. (6) If assessing whether a patient with a Charcot foot has a superimposed infection, however, WBC scintigraphy may be more accurate than [18F]FDG PET/CT in differentiating OM from Charcot arthropathy. (7) Whenever possible, microbiological or histological assessment should be performed to confirm the diagnosis. (8) Consider appealing to an additional imaging modality in a patient with persisting clinical suspicion of infection, but negative imaging. CONCLUSION: These practical recommendations highlight, and should assist clinicians in understanding, the role of imaging in the diagnostic workup of diabetic foot complications.
引用
- Lauri C, Noriega-Álvarez E, Chakravartty RM, et al. Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance. Eur J Nucl Med Mol Imaging. 2024. PMID: 38532027. doi:10.1007/s00259-024-06693-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。